e-learning
resources
Stockholm 2007
Monday 17.09.2007
Neonatal respiratory disorders: pathogenesis, management and outcomes
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The role of proteases in the development of chronic lung disease of prematurity (CLD)
P. L. Davies, N. C. Maxwell, O. B. Spiller, S. Kotecha (Cardiff, United Kingdom)
Source:
Annual Congress 2007 - Neonatal respiratory disorders: pathogenesis, management and outcomes
Session:
Neonatal respiratory disorders: pathogenesis, management and outcomes
Session type:
Thematic Poster Session
Number:
2331
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. L. Davies, N. C. Maxwell, O. B. Spiller, S. Kotecha (Cardiff, United Kingdom). The role of proteases in the development of chronic lung disease of prematurity (CLD). Eur Respir J 2007; 30: Suppl. 51, 2331
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
European Respiratory Society guideline on long term management of children with bronchopulmonary dysplasia
PP306 – Submicroscopic changes of type I alveolocytes in the early stages of experimental diabetes mellitus
Related content which might interest you:
The role of anti-proteases in the development of chronic lung disease of prematurity (CLD)
Source: Annual Congress 2007 - Chronic lung disease of prematurity: pathogenesis and outcomes
Year: 2007
The role of infection in the development of chronic lung disease of prematurity
Source: Annual Congress 2007 - Chronic lung disease of prematurity: pathogenesis and outcomes
Year: 2007
Impact of prematurity on rabbit lung development: a key factor for mimicking chronic neonatal lung disease
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021
The role of ASC signalling in preterm infants at risk of chronic lung disease of prematurity
Source: International Congress 2018 – Prematurity and lung disease
Year: 2018
Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity
Source: Annual Congress 2008 - Physiological year in review
Year: 2008
The role of surfactant on chronic infant lung disease
Source: Annual Congress 2003 - Chronic infant lung disease
Year: 2003
Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007
Delayed neutrophil apoptosis may predispose to lung injury in chronic lung disease of prematurity
Source: Eur Respir J 2007; 30: Suppl. 51, 393s
Year: 2007
Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort
Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Year: 2007
The role smoking in development of dust-indusde chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 608s
Year: 2004
Role of pulmonary infection in the development of chronic lung disease of prematurity
Source: Eur Respir J 2011; 37: 1424-1430
Year: 2011
Senotherapies for chronic lung disease
Source: ERS Lung Science Conference 2020
Year: 2020
Predictive factors for the incidence of lung cancer (LC) complicated in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019
Rate of progression of lung function impairment in α1-antitrypsin deficiency
Source: Eur Respir J 2009; 33: 1338-1344
Year: 2009
Matrix metalloproteinases and lung disease severity in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 249s
Year: 2001
Interstitial lung diseases in infants and children
Source: Eur Respir J 2008; 31: 658-666
Year: 2008
Frequency and features of formation of chronic kidney disease (CKD) in patients with chronic obstructive pulmonary disease.
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals
Source: Eur Respir J 2011; 37: 791-799
Year: 2011
Implication of microRNA-148b in chronic obstructive lung disease of betaENaC-overexpressing mice
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept